vs
Side-by-side financial comparison of Laser Photonics Corp (LASE) and China SXT Pharmaceuticals, Inc. (SXTC). Click either name above to swap in a different company.
Laser Photonics Corp is the larger business by last-quarter revenue ($919.3K vs $829.5K, roughly 1.1× China SXT Pharmaceuticals, Inc.). China SXT Pharmaceuticals, Inc. runs the higher net margin — -96.8% vs -506.4%, a 409.7% gap on every dollar of revenue. On growth, Laser Photonics Corp posted the faster year-over-year revenue change (28.3% vs 0.0%).
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
China SXT Pharmaceuticals, Inc. is a pharmaceutical company focused on the Chinese domestic market. It engages in the research, development, production and distribution of traditional Chinese medicine-based prescription drugs, over-the-counter medications, and nutritional health products, serving both clinical medical institutions and consumer health markets.
LASE vs SXTC — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $919.3K | $829.5K |
| Net Profit | $-4.7M | $-802.6K |
| Gross Margin | -20.1% | 16.2% |
| Operating Margin | -350.0% | -76.9% |
| Net Margin | -506.4% | -96.8% |
| Revenue YoY | 28.3% | 0.0% |
| Net Profit YoY | -186.5% | 0.0% |
| EPS (diluted) | $-0.27 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $919.3K | $829.5K | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $2.3M | — | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $716.7K | $829.5K | ||
| Q2 24 | $623.4K | — | ||
| Q1 24 | $743.0K | — | ||
| Q4 23 | $994.6K | — |
| Q3 25 | $-4.7M | $-802.6K | ||
| Q2 25 | $-1.8M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $586.4K | — | ||
| Q3 24 | $-1.6M | $-802.6K | ||
| Q2 24 | $-934.3K | — | ||
| Q1 24 | $-545.7K | — | ||
| Q4 23 | $-486.6K | — |
| Q3 25 | -20.1% | 16.2% | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | 49.8% | — | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 85.0% | 16.2% | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 51.9% | — | ||
| Q4 23 | 84.5% | — |
| Q3 25 | -350.0% | -76.9% | ||
| Q2 25 | -37.0% | — | ||
| Q1 25 | -68.7% | — | ||
| Q4 24 | -255.1% | — | ||
| Q3 24 | -238.0% | -76.9% | ||
| Q2 24 | -149.4% | — | ||
| Q1 24 | -73.8% | — | ||
| Q4 23 | -88.4% | — |
| Q3 25 | -506.4% | -96.8% | ||
| Q2 25 | -68.3% | — | ||
| Q1 25 | -73.4% | — | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | -226.8% | -96.8% | ||
| Q2 24 | -149.9% | — | ||
| Q1 24 | -73.4% | — | ||
| Q4 23 | -48.9% | — |
| Q3 25 | $-0.27 | — | ||
| Q2 25 | $-0.12 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $-0.13 | $-0.25 | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.06 | — | ||
| Q4 23 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $18.1M |
| Total DebtLower is stronger | — | $105.0K |
| Stockholders' EquityBook value | $4.1M | $15.4M |
| Total Assets | $17.5M | $21.7M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $3.6M | $18.1M | ||
| Q2 25 | $78.5K | — | ||
| Q1 25 | $179.1K | — | ||
| Q4 24 | $533.9K | — | ||
| Q3 24 | $2.1M | $18.5M | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $5.2M | — | ||
| Q4 23 | $6.2M | — |
| Q3 25 | — | $105.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $952.3K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | $4.1M | $15.4M | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | $6.8M | — | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $9.7M | $15.0M | ||
| Q2 24 | $10.3M | — | ||
| Q1 24 | $12.4M | — | ||
| Q4 23 | $13.9M | — |
| Q3 25 | $17.5M | $21.7M | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | $16.0M | — | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $10.6M | $31.0M | ||
| Q2 24 | $11.1M | — | ||
| Q1 24 | $13.6M | — | ||
| Q4 23 | $15.1M | — |
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $763.1K | $-1.4M |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -216.2% |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $763.1K | $-1.4M | ||
| Q2 25 | $-1.0M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $632.7K | $-1.4M | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-866.3K | — | ||
| Q4 23 | $-2.0M | — |
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $589.6K | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-1.0M | — | ||
| Q4 23 | — | — |
| Q3 25 | — | -216.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 82.3% | — | ||
| Q2 24 | -388.0% | — | ||
| Q1 24 | -136.9% | — | ||
| Q4 23 | — | — |
| Q3 25 | — | 4.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 20.3% | — | ||
| Q4 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -11.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
